Faecal calprotectin for the diagnosis of inflammatory bowel disease

BMJ (Online)

Volumn 341, Issue 7765, 2010, Pages 159-

  Logan, Robert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN;

CAPSULE ENDOSCOPY; COLONOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EDITORIAL; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FECES ANALYSIS; HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; META-ANALYSIS AS TOPIC;

EID: 77955104699     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3636     Document Type: Editorial

References (6)

1. Van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.[Abstract/Free Full Text]
2. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in faeces. A methodological study. Scan J Gastroenterol 1992;27:793-8.[Web of Science] [Medline]
3. Whitehead SJ, Lee L, Fang Z, Sisson G, Hutton J, Logan RPH. Can faecal calprotectin reduce the demand for colonoscopy in patients with irritable bowel syndrome [abstract]. Gut 2010;59(suppl 1):A36. [CrossRef][Web of Science]
4. Moore JK, West S, Kelly S, Robins G. To determine the negative predictive value of faecal calprotectin in predicting future organic gastrointestinal disease [abstract]. Gut 2010;59(suppl 1):A37. [CrossRef][Web of Science]
5. Walkden A, Clark A, Dart R. Clinical utility of faecal calprotectin in diagnosing inflammatory bowel disease during first presentation to the gastroenterology clinic: a novel investigative algorithm [abstract]. Gut 2010;59 (suppl 1):A6.
6. Department of Health. Value of calprotectin in screening out irritable bowel syndrome (09041 and 09026). www.cep.dh.gov.uk/CEPProducts/Catalogue.aspx.